ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 139 filers reported holding ARRAY BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 3.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $38,804,000 | -10.6% | 837,563 | -52.9% | 0.91% | -7.2% |
Q1 2019 | $43,394,000 | +66.3% | 1,779,884 | -2.8% | 0.98% | +45.4% |
Q4 2018 | $26,094,000 | -10.9% | 1,831,159 | -5.0% | 0.67% | +10.9% |
Q3 2018 | $29,299,000 | -21.3% | 1,927,536 | -13.1% | 0.61% | -20.6% |
Q2 2018 | $37,235,000 | -12.2% | 2,219,024 | -14.6% | 0.77% | -7.8% |
Q1 2018 | $42,413,000 | +22.0% | 2,598,828 | -4.3% | 0.83% | +24.4% |
Q4 2017 | $34,777,000 | -4.7% | 2,716,983 | -8.5% | 0.67% | -0.7% |
Q3 2017 | $36,508,000 | +42.9% | 2,968,108 | -2.8% | 0.67% | +37.1% |
Q2 2017 | $25,549,000 | -6.7% | 3,052,448 | -0.4% | 0.49% | -6.1% |
Q1 2017 | $27,388,000 | -2.9% | 3,063,577 | -4.5% | 0.52% | -8.1% |
Q4 2016 | $28,212,000 | +23.1% | 3,209,507 | -5.5% | 0.57% | +23.7% |
Q3 2016 | $22,915,000 | +84.2% | 3,394,817 | -2.8% | 0.46% | +71.6% |
Q2 2016 | $12,439,000 | +19.8% | 3,494,127 | -0.7% | 0.27% | +20.7% |
Q1 2016 | $10,382,000 | -28.8% | 3,519,267 | +1.9% | 0.22% | -27.5% |
Q4 2015 | $14,574,000 | -13.9% | 3,453,487 | -6.9% | 0.31% | -18.2% |
Q3 2015 | $16,920,000 | -38.6% | 3,710,420 | -2.9% | 0.37% | -26.8% |
Q2 2015 | $27,543,000 | -5.3% | 3,820,053 | -3.2% | 0.51% | -5.9% |
Q1 2015 | $29,086,000 | +56.6% | 3,946,483 | +0.5% | 0.54% | +49.2% |
Q4 2014 | $18,575,000 | +39.5% | 3,926,968 | +5.3% | 0.36% | +34.3% |
Q3 2014 | $13,313,000 | +12.3% | 3,729,223 | +43.4% | 0.27% | +17.3% |
Q2 2014 | $11,856,000 | -11.5% | 2,599,933 | -8.8% | 0.23% | -11.5% |
Q1 2014 | $13,395,000 | -9.4% | 2,850,023 | -3.4% | 0.26% | -9.7% |
Q4 2013 | $14,781,000 | +2.0% | 2,950,263 | +26.6% | 0.29% | -3.7% |
Q3 2013 | $14,497,000 | – | 2,330,780 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|